Ketone-IQ for Sleep Apnea
(KETO-SLEEP 2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether Ketone-IQ, a type of exogenous ketone (a substance produced by the body during a keto diet), can improve sleep quality and reduce the severity of obstructive sleep apnea (OSA), a condition that disrupts breathing during sleep. Participants will use Ketone-IQ and a placebo (a substance with no active ingredient) on different nights to observe any differences. The trial targets individuals with moderate to severe OSA who regularly use a CPAP machine (a device that keeps airways open during sleep). As a Phase 1, Phase 2 trial, the research aims to understand how Ketone-IQ works in people and to measure its effectiveness in an initial, smaller group.
Do I have to stop taking my current medications for the trial?
The trial requires you to stop using nightly medications that affect breathing and Sodium-glucose cotransporter-2 (SGLT2) inhibitors. If you are taking these, you will need to stop before participating.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Earlier studies have shown that Ketone-IQ, which contains 1,3 butanediol, may benefit brain function and overall health. This suggests it has been generally well-received in past uses. Although specific safety information for sleep apnea is limited, current research is examining short-term responses to Ketone-IQ. As a purchasable product, many have used it without major issues. However, since testing for sleep apnea is still in early stages, participation in studies is crucial to confirm its safety and effectiveness for this condition.12345
Why do researchers think this study treatment might be promising for sleep apnea?
Unlike the standard treatments for sleep apnea, such as CPAP machines and oral appliances, Ketone-IQ offers a novel approach by utilizing ketone bodies to potentially improve sleep quality. Researchers are keen to explore this treatment because ketone bodies might enhance brain energy metabolism during sleep, which is a different mechanism than simply mechanically supporting airways. This innovative angle could lead to better patient compliance and offer benefits beyond what's currently available.
What evidence suggests that Ketone-IQ might be an effective treatment for sleep apnea?
This trial will evaluate the effects of Ketone-IQ on sleep apnea. Research has shown that a low-carb, high-fat ketogenic diet can reduce the severity of obstructive sleep apnea (OSA). Since following this diet can be challenging, supplements like Ketone-IQ might offer a useful alternative. Studies have found that these supplements can improve sleep quality, especially after intense exercise. The idea is that taking Ketone-IQ before bed could raise ketone levels overnight, potentially alleviating OSA symptoms. Although human research on Ketone-IQ for OSA is limited, early studies suggest a positive effect. Participants in this trial will experience both Ketone-IQ and placebo treatments in a crossover design to assess its impact on OSA.12367
Who Is on the Research Team?
Jonathan Jun, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for individuals with Obstructive Sleep Apnea (OSA), a condition that disrupts sleep and increases heart disease risk. Participants should be interested in trying an alternative to the challenging ketogenic diet by taking Ketone-IQ at bedtime to potentially improve their sleep quality and reduce OSA severity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants ingest exogenous ketones (Ketone-IQ) or placebo before sleep to assess effects on sleep apnea and related symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Ketone-IQ
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
HVMN Inc
Industry Sponsor
KETONE-IQ
Collaborator